Details for New Drug Application (NDA): 207809
✉ Email this page to a colleague
The generic ingredient in MELPHALAN is melphalan hydrochloride. There are twelve drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the melphalan hydrochloride profile page.
Summary for 207809
Tradename: | MELPHALAN |
Applicant: | Alvogen |
Ingredient: | melphalan |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 207809
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Mar 22, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription